IRadimed Corp (NASDAQ:IRMD) Q2 2020 Earnings Conference Call July 30, 2020 11:00 AM ET Company Participants Roger Susi - President and Chief Executive Officer Chris Scott - Chief Financial Officer Conference Call Participants Lisa Springer - Singular Research Operator Welcome to IRadimed Corporation's Second Quarter 2020 Financial Results Conference Call. [Operator instructions] As a reminder, this call is being recorded today, July 30, 2020, and contains time-sensitive information that is accurate only as ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2020 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-36534 IRADIMED CORPORATION (Exact name of Registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer incorporat ...

IRadimed Corporation (NASDAQ:IRMD) Q1 2020 Earnings Conference Call April 30, 2020 11:00 AM ET Company Participants Leslie McDonnell - President and CEO Chris Scott - CFO Conference Call Participants Scott Henry - Roth Capital Lisa Springer - Singular Research Operator Welcome to the IRadimed Corporation First Quarter 2020 Financial Results Conference Call. Currently, all participants are in a listen-only mode. And at the end of the call, we will conduct a question-and-answer session. As a reminder, this ca ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NO. 001-36534 IRADIMED CORPORATION (Exact Name of Registrant As Specified In Its Charter) Delaware 73-1408526 (State or other jurisdiction of (I.R.S. Emplo ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-36534 IRADIMED CORPORATION (Exact name of Registrant as specified in its charter) Delaware 73-1408526 (State or other j ...

Start Time: 11:00 January 1, 0000 11:29 AM ET IRADIMED Corporation (NASDAQ:IRMD) Q3 2019 Earnings Conference Call October 30, 2019, 11:00 AM ET Company Participants Leslie McDonnell - President and CEO Chris Scott - CFO and Secretary Roger Susi - Chairman, CTO Brent Johnson - EVP of Worldwide Sales and Marketing Conference Call Participants Scott Henry - ROTH Capital Lisa Springer - Singular Research Operator Ladies and gentlemen, thank you for standing by. Welcome to the IRADIMED Corporation Third Quarter ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the Quarterly Period Ended June 30, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-36534 IRADIMED CORPORATION (Exact name of Registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number 1025 Willa Springs Drive Winte ...

IRadimed Corp (NASDAQ:IRMD) Q2 2019 Earnings Conference Call July 30, 2019 11:00 AM ET Company Participants Roger Susi - Founder, Chairman, CEO & President Brent Johnson - EVP, Worldwide Sales & Marketing Christopher Scott - CFO & Secretary Conference Call Participants Operator Ladies and gentlemen, thank you for standing by. Welcome to IRadimed Corporation Second Quarter 2019 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, July 30, 201 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-36534 IRADIMED CORPORATION (Exact name of Registrant as specified in its charter) Delaware 73-1408526 (State or other juris ...

IRadimed Corp (NASDAQ:IRMD) Q1 2019 Earnings Conference Call April 30, 2019 11:00 AM ET Company Participants Roger Susi - Founder, Chairman, CEO & President Brent Johnson - EVP, Worldwide Sales & Marketing Christopher Scott - CFO & Secretary Conference Call Participants Stefanos Crist - CJS Securities Scott Henry - Roth Capital Partners Operator Ladies and gentlemen, thank you for standing by. Welcome to the IRADIMED Corporation First Quarter 2019 Financial Results Conference Call. [Operator Instructions]. ...